NeuroOne Medical Technologies Corporation Operating Lease, Payments
NeuroOne Medical Technologies Corporation (NMTC) reported Operating Lease, Payments of $103.70 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-13
- NeuroOne Medical Technologies Corporation operating lease, payments for the quarter ending 2026-06-30 was $35.16K, a 65.67% increase year-over-year.
- NeuroOne Medical Technologies Corporation operating lease, payments for the quarter ending 2026-03-31 was $68.53K, a 3.69% decline year-over-year.
- NeuroOne Medical Technologies Corporation operating lease, payments for the quarter ending 2025-12-31 was $34.05K, a 3.06% decline year-over-year.
- NeuroOne Medical Technologies Corporation operating lease, payments for the quarter ending 2025-09-30 was $34.05K, a 3.07% decline year-over-year.
- NeuroOne Medical Technologies Corporation operating lease, payments for fiscal 2025 was $126.44K, a 8.99% decline from fiscal 2024.
- NeuroOne Medical Technologies Corporation operating lease, payments for fiscal 2024 was $138.92K, a 3.18% increase from fiscal 2023.
- NeuroOne Medical Technologies Corporation operating lease, payments for fiscal 2023 was $134.63K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $35.16K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2026-08-13 | $103.70K derived: sum of 2 quarters · filed 2026-08-13 | $103.70K 10-Q · filed 2026-08-13 | $171.79K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $68.53K 10-Q · filed 2026-05-12 | $68.53K 10-Q/A · filed 2026-06-12 | $136.63K derived: sum of 3 quarters · filed 2026-05-12 | $157.85K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $34.05K 10-Q · filed 2026-02-17 | $68.09K derived: sum of 2 quarters · filed 2026-02-17 | $89.32K derived: sum of 3 quarters · filed 2026-08-13 | $160.48K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-09-30 | $34.05K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $55.27K derived: sum of 2 quarters · filed 2026-08-13 | $126.44K derived: sum of 3 quarters · filed 2026-08-13 | $126.44K 10-K · filed 2025-12-17 |
| 2025-06-30 | $21.23K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2026-08-13 | $92.39K derived: sum of 2 quarters · filed 2026-08-13 | $92.39K 10-Q · filed 2026-08-13 | $162.63K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $71.16K 10-Q · filed 2026-05-12 | $71.16K 10-Q/A · filed 2026-06-12 | $141.41K derived: sum of 3 quarters · filed 2026-05-12 | $176.53K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $35.12K 10-Q · filed 2026-02-17 | $70.24K derived: sum of 2 quarters · filed 2026-02-17 | $105.37K derived: sum of 3 quarters · filed 2026-02-17 | $139.97K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | $35.12K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $70.24K derived: sum of 2 quarters · filed 2025-12-17 | $104.85K derived: sum of 3 quarters · filed 2025-12-17 | $138.92K 10-K · filed 2025-12-17 |
| 2024-06-30 | $35.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-14 | $69.72K derived: sum of 2 quarters · filed 2025-08-14 | $103.80K 10-Q · filed 2025-08-14 | $137.87K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $34.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-13 | $68.67K 10-Q · filed 2025-05-13 | $102.74K derived: sum of 3 quarters · filed 2025-05-13 | $136.81K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $34.07K 10-Q · filed 2025-02-12 | $68.14K derived: sum of 2 quarters · filed 2025-02-12 | $102.21K derived: sum of 3 quarters · filed 2025-02-12 | $135.77K derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $34.07K derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-17 | $68.14K derived: sum of 2 quarters · filed 2024-12-17 | $101.70K derived: sum of 3 quarters · filed 2024-12-17 | $134.63K 10-K · filed 2024-12-17 |
| 2023-06-30 | $34.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-14 | $67.63K derived: sum of 2 quarters · filed 2024-08-14 | $100.56K 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $33.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-14 | $66.49K 10-Q · filed 2024-05-14 | ||
| 2022-12-31 | $32.93K 10-Q · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |